Prospects for the treatment of cancer patients with joint use of BRT and KD immunomodulator (cucumaridosis)

Prospects for the treatment of cancer patients with joint use of BRT and KD immunomodulator (cucumaridosis)

AUTHORS : Sobotovich S.L. | Boguslavsky V.M.

RELEVANT UNIVERSITIES : Regional Clinical Hospital, Pacific Institute of Bioorganic Chemistry DVORAN, Vladivostok, Russia
YEAR : 2001 | Category : Method of treatment

The drug KD – the sum of triterpene glycosides, isolated from Japanese cucumaria, is one of the most active drugs among the known immunomodulators (Sedov A.M., Elkina S.I., etc.). One of the mechanisms of its biochemical action is the activation of macrophages. Triterpene glycosides isolated from sea cucumbers are able to stimulate antibacterial resistance against salmonellosis in mice [one].

The drug KD enhances the body’s resistance to diseases caused by a number of gram-negative microorganisms, and some viral diseases. It is used in veterinary medicine to prevent a number of diseases of farm animals and fur animals. A number of interesting features:

مطالب دیگر

Next Post
Assessment of the quality of life of children with viral hepatitis B and vegetative-vascular dystonia in dynamics when using bioresonance therapy
Previous Post
Experience of using the theory of five primary elements to optimize treatment using the hardware and software complex “IMEDIS-FALL”
برای نوشتن دیدگاه باید وارد بشوید.
فهرست